GlobalData on MSN1d
Latigo secures $150m for non-opioid pain treatment development
Latigo Biotherapeutics has secured $150m in a Series B financing round, which will be used to further the development of its ...
Business Wire12d
Tris Pharma Announces Positive Results from ALLEVIATE-2 Phase 3 Pivotal Trial for Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Trea…
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...
Fierce Biotech2d
Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic
Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...
Young adults in pain start using cannabis earlier and are more likely to mix it with alcohol, research finds
Contrary to popular belief, young adults can experience significant acute and even chronic pain—which can motivate them to ...
Verywell Health on MSN1d
Understanding Urethral Syndrome and What Causes It
Urethral syndrome causes spasms in the urethra, pain during urination, and the frequent urge to pee. Learn why treatment may ...
The 5 Easiest Health Habits To Keep Chronic Inflammation Under Control, According To Doctors
Reducing sleep to four hours for just one night has been shown to elevate inflammatory markers in the body, research has ...
Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward
Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute ...
EL PAÍS English11d
The notebooks of a pedophile surgeon
Joël Le Scouarnec described the 299 rapes or sexual assaults he committed over 24 years in detail and stored his notes away ...
Pacira BioSciences: Back On An Uptrend After Positive Developments
Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...
'I thought I just had a bad headache – now I'm learning to walk and talk again'
Doctors at Maidstone Hospital in Kent found Phoebe O’Shaughnessy's extreme symptoms were caused by an autoimmune condition ...